Actinium Pharmaceuticals, Inc. Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
5/16/2013 10:24:50 AM
More...
|
Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
5/13/2013 9:56:14 AM
More...
|
Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
4/18/2013 9:18:43 AM
More...
|
Actinium Pharmaceuticals, Inc. to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO Investor Conference
2/6/2013 1:58:29 PM
More...
|
Actinium Pharmaceuticals, Inc. to Present at EMIT Targeted Radiotherapy Conference
1/28/2013 6:35:49 AM
More...
|
University of Pennsylvania Joins Actinium Pharmaceuticals, Inc.' Multicenter Actimab-A Trial
1/17/2013 10:13:17 AM
More...
|
Actinium Pharmaceuticals, Inc. Goes Public via a Reverse Merger into Cactus Ventures, Inc.
1/4/2013 9:12:42 AM
More...
|
Actinium Pharmaceuticals, Inc. to Present at the Biotech Showcase 2013
1/4/2013 6:52:10 AM
More...
|
Actinium Pharmaceuticals, Inc. Raises $5.1 Million
12/27/2012 8:42:32 AM
More...
|
Actinium Pharmaceuticals, Inc. Release: Additional Clinical Data From Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
12/5/2012 9:13:30 AM
More...
|
|